Green Cross Medical Science Corporation
Green Cross Medical Science Corporation manufactures and sells diagnostic reagents and medical devices in South Korea and internationally. The company offers immunology diagnostic reagents. It also provides COVID-19 kit; blood glucose monitoring system; HbA1c test machine; and Gcare LIPID and LIPID printer. Green Cross Medical Science Corporation was founded in 1972 and is headquartered in Yongin… Read more
Green Cross Medical Science Corporation (142280) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.090x
Based on the latest financial reports, Green Cross Medical Science Corporation (142280) has a cash flow conversion efficiency ratio of 0.090x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩4.22 Billion) by net assets (₩46.80 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Green Cross Medical Science Corporation - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Green Cross Medical Science Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Green Cross Medical Science Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Green Cross Medical Science Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
H.H.Galaxy Co., Ltd.
TWO:2949
|
-0.215x |
|
Taiwan Name Plate Co. Ltd.
TWO:6593
|
0.002x |
|
PT Wijaya Karya (Persero) Tbk
F:5AA
|
0.007x |
|
DIVA Laboratories Ltd
TWO:4153
|
0.053x |
|
EVERCHINA INT.HDGS.
F:ICHA
|
N/A |
|
Thantawan Industry Public Company Limited
BK:THIP
|
-0.005x |
|
Cobre Ltd
AU:CBE
|
-0.030x |
|
Berjaya Assets Bhd
KLSE:3239
|
0.009x |
Annual Cash Flow Conversion Efficiency for Green Cross Medical Science Corporation (2014–2024)
The table below shows the annual cash flow conversion efficiency of Green Cross Medical Science Corporation from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩41.21 Billion | ₩3.66 Billion | 0.089x | -22.67% |
| 2023-12-31 | ₩36.92 Billion | ₩4.24 Billion | 0.115x | -64.89% |
| 2022-12-31 | ₩33.25 Billion | ₩10.88 Billion | 0.327x | +164.94% |
| 2021-12-31 | ₩36.11 Billion | ₩-18.20 Billion | -0.504x | -224.76% |
| 2020-12-31 | ₩56.47 Billion | ₩-8.76 Billion | -0.155x | -87.24% |
| 2019-12-31 | ₩49.58 Billion | ₩-4.11 Billion | -0.083x | -146.02% |
| 2018-12-31 | ₩15.34 Billion | ₩-516.61 Million | -0.034x | -125.18% |
| 2017-12-31 | ₩23.23 Billion | ₩3.11 Billion | 0.134x | -64.95% |
| 2016-12-31 | ₩26.85 Billion | ₩10.25 Billion | 0.382x | +302.32% |
| 2015-12-31 | ₩28.87 Billion | ₩-5.45 Billion | -0.189x | -167.97% |
| 2014-12-31 | ₩31.50 Billion | ₩-2.22 Billion | -0.070x | -- |